Healthcare -
Biotechnology - NASDAQ - US
$ 5.5
5.16 %
$ 49 M
Market Cap
-11.22
P/E
ICCC - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ICCC - ImmuCell Corporation
1.75 M
LAST VALUE
-32.80%
2 YEAR CAGR
14.51%
5 YEAR CAGR
29.23%
10 YEAR CAGR